Expression of keratinocyte growth factor (KGF) and its receptor in a middle-ear cavity problem

International Journal of Pediatric Otorhinolaryngology

Volumn 76, Issue 1, 2012, Pages 76-81

  Yamamoto Fukuda, Tomomi ^a   Takahashi, Haruo ^a   Koji, Takehiko ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

B cell; Cavity problem; Immunohistochemistry; Keratinocyte growth factor (KGF); KGF receptor (KGFR); Ki 67

Indexed keywords

KERATINOCYTE GROWTH FACTOR; KERATINOCYTE GROWTH FACTOR RECEPTOR; KI 67 ANTIGEN;

ADULT; ARTICLE; B LYMPHOCYTE; CELL PROLIFERATION; CHOLESTEATOMA; CONTROLLED STUDY; EAR SURGERY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; MIDDLE EAR DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; T LYMPHOCYTE;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; BIOPSY, NEEDLE; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CHOLESTEATOMA, MIDDLE EAR; EAR, MIDDLE; FEMALE; FIBROBLAST GROWTH FACTOR 7; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; RETROSPECTIVE STUDIES; RISK ASSESSMENT; YOUNG ADULT;

EID: 84855554298     PISSN: 01655876     EISSN: 18728464     Source Type: Journal    
DOI: 10.1016/j.ijporl.2011.10.003     Document Type: Article

References (31)

1. Portmann M. The problem of the cavity in tympanoplastic surgery. Laryngoscope 1971, 81:1233-1241.
2. Brandow E.C. Surgical procedure for the mastoid cavity problem. Otolaryngol Head Neck Surg. 1980, 88:622-624.
3. Jackson C.G., Glasscock M.E., Nissen A.J., Schwaber M.K., Bojrab D.I. Open mastoid procedures: contemporary indications and surgical technique. Laryngoscope 1985, 95(9 Pt. 1):1037-1043.
4. Rambo J.H.T. Primary closure of the radical mastoidectomy wound: a technique to eliminate postoperative care. Laryngoscope 1958, 68:1216-1227.
5. Palva T. Surgery of chronic ear with cavity. Arch. Otolaryngol. 1963, 77:570-579.
6. Sade J. Reconstruction of the posterior canal wall in obliteration of radical mastoidectomies. Arch. Otolaryngol. 1963, 78:127-129.
7. Turner J.L. Obliteration of mastoid cavities by musculoplasty. Laryngoscope 1966, 76:465-471.
8. Birzgalis A.R., Farrington W.T., O'Keefe L. Reconstruction of discharging mastoid cavities using the temporalis myofascial flap. Clin. Otolaryngol. 1994, 19:70-72.
9. Finch P.W., Rubin J.S., Miki T., Ron D., Aaronson S.A. Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth. Science 1989, 245:752-755.
10. Koji T., Chedid M., Rubin J.S., Slayden O.D., Csaky K.G., et al. Progesterone-dependent expression of keratinocyte growth factor mRNA in stromal cells of the primate endometrium: keratinocyte growth factor as a progestomedin. J. Cell Biol. 1994, 125:393-401.
11. Werner S., Peters K.G., Longaker M.T., Fuller-Pace F., Banda M.J., Williams L.T. Large induction of keratinocyte growth factor expression in the dermis during wound healing. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:6896-6900.
12. Staiano-Coico B.L., Kruegter J.G., Rubin J.S., D'limi S., Vallat V.P., Valentino L., et al. Human keratinocyte growth factor effects in a porcine model of epidermal wound hearing. J. Exp. Med. 1993, 178:865-878.
13. Yamamoto-Fukuda T., Aoki D., Hishikawa Y., Kobayashi T., Takahashi H., Koji T. Possible involvement of keratinocyte growth factor and its receptor in enhanced epithelial-cell proliferation and acquired recurrence of middle-ear cholesteatoma. Lab. Invest. 2003, 83:123-136.
14. Yamamoto-Fukuda T., Terakado M., Hishikawa Y., Koji T., Takahashi H. Topical application of 5-fluorouracil on attic cholesteatoma results in downregulation of keratinocyte growth factor and reduction of proliferative activity. Eur. Arch. Otorhinolaryngol. 2008, 265:1173-1178.
15. Yamamoto-Fukuda T., Takahashi H., Terakado M., Hishikawa Y., Koji T. Expression of keratinocyte growth factor and its receptor in noncholesteatomatous and cholesteatomatous chronic otitis media. Otol. Neurotol. 2010, 31:745-751.
16. Sculerati N., Bluestone C.D. Pathogenesis of cholesteatoma. Otolaryngol. Clin. North Am. 1989, 22:859-868.
17. Sudhoff H., Bujia J., Fisseler-Eckhoff A., Holly A., Schulz-Flanke C., Hildmann H. Expression of a cell-cycle-associated nuclear antigen (MIB 1) in cholesteatoma and auditory meatal skin. Laryngoscope 1995, 105:1227-1231.
18. Wright C.W., Meyerhoff W.M. Pathology of otitis media. Ann. Otol. Rhinol. Laryngol. 1994, 103:24-26.
19. Nishino N., Ito S., Suzuki H., Isobe K. Antibodies to wound tissue enhance cutaneous wound hearing. Immunology 2009, 128:369-380.
20. Brandtzaeg P. Role of immune system-dangers of a nonholistic approach in explaining health and disease. Periodontology Today 1988, 196. Karger, Basel, Switzerland. V.B. Gugpenheim (Ed.).
21. Ziff M. Emigration of lymphocytes in rheumatoid synovitis. Aduan Inflamm. Res. 1988, 12:1.
22. Elson C.O. The immunology of inflammatory bowel disease. Inflammatory Bowel Disease 1988, 97. Lea and Febiger, Philadelphia, PA. J.B. Kirsner, R.G. Shorter (Eds.).
23. Adams J.C. Heavy metal intensification of DAB-based HRP reaction product. J. Histochem. Cytochem. 1981, 29:775.
24. Ehara H., Koji T., Deguchi T., Yoshii A., Nakano M., Nakane P.K., et al. Expression of estrogen receptor in diseased human prostate assessed by non-radioactive in situ hybridization and immunohistochemistry. Prostate 1995, 27:304-313.
25. Norton A.J., Ramsay A.D., Smith S.H., Beverley P.C., Isaacson P.G. Monoclonal antibody (UCHL1) that recognises normal and neoplastic T cells in routinely fixed tissues. J. Clin. Pathol. 1986, 39:399-405.
26. Cartun R.W., Coles F.B., Pastuszak W.T. Utilization of monoclonal antibody L26 in the identification and confirmation of B-cell lymphomas. A sensitive and specific marker applicable to formalin-and B5-fixed, paraffin-embedded tissues. Am. J. Pathol. 1987, 129:415-421.
27. Mason D. The role of B cells in the programming of T cells for IL-4 synthesis. J. Exp. Med. 1996, 183:717-719.
28. Martin F., Chan A.C. Pathogenic roles of B cells in human autoimmunity; insights from the clinic. Immunity 2004, 20:517-527.
29. Bombardieri M., Barone F., Humby F., Kelly S., McGurk M., Morgan P., et al. Activation-induced cytidine deaminase expression in follicular dendritic cell networks and interfollicular large B cells supports functionality of ectopic lymphoid neogenesis in autoimmune sialoadenitis and MALT lymphoma in Sjogren's syndrome. J. Immunol. 2007, 179:4929-4938.
30. Timmer T.C., Baltus B., Vondenhoff M., Huizinga T.W., Tak P.P., Verweij Cl, et al. Inflammation and ectopic lymphoid structures in rheumatoid arthritis synovial tissues dissected by genomics technology: identification of the interleukin-7 signaling pathway in tissues with lymphoid neogenesis. Arthritis Rheum. 2007, 56:2492-2502.
31. Nagel A., Hertl M., Eming R. B-cell-directed therapy for inflammatory skin diseases. J. Invest. Dermatol. 2009, 129:289-301.